Table 4.
Percentage of phenotypically unsusceptible strains of Aeromonas spp. among ceftazidime, meropenem, and ampicillin resistant Aeromonas spp. isolated from influent, activated sludge, and effluent of UWTP.
| Sampling point | CTX | CAZ | FEP | ATM | ERT | IMP | MEM | CIP | TE | C | CN | AK | MDR > 3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Influent | 5% | 56% | 95% | 13% | 3% | 3% | 3% | 3% | 21% | 67% | 38% | 100% | 74% |
| Activated sludge | 13% | 44% | 71% | 27% | 11% | 18% | 22% | 11% | 29% | 69% | 36% | 100% | 69% |
| Effluent | 10% | 45% | 55% | 20% | 10% | 5% | 5% | 0% | 15% | 70% | 30% | 100% | 60% |
| Summary | 10% | 49% | 77% | 20% | 8% | 10% | 12% | 6% | 23% | 68% | 36% | 100% | 68% |
CTX, cefotaxime; CAZ, ceftazidime; FEP, cefepime; AZT, aztreonam; ERT, ertapenem; IMP, imipenem; MEM, meropenem; CIP, ciprofloxacin; TET, tetracycline; C, chloramphenicol; CN, gentamicin; AK, amikacin; MDR, multidrug resistance strains.